Skip to content
Veracy Advisory Platform
← All tools

HeartFlow

FDA-cleared AI that creates 3D models of coronary arteries from CT scans to guide heart disease diagnosis without invasive tests.

Listed Needs re-verification
Clinical Decision $$$ Enterprise Healthcare

What it does

HeartFlow is a medical AI company with FDA clearance that creates a digital 3D model of a patient's coronary arteries from a standard CT scan - using computational fluid dynamics and AI to simulate blood flow and calculate fractional flow reserve (FFR) without requiring invasive catheterization. HeartFlow FFRCT gives cardiologists a non-invasive way to assess whether coronary artery narrowings are functionally significant, enabling more informed treatment decisions. AI capabilities include deep learning CT image segmentation that reconstructs coronary anatomy in 3D, fluid dynamics simulation that models physiological blood flow, and AI-assisted reporting that summarizes findings for cardiologist review.

Strengths

  • Large cardiac care centers, academic medical centers, and cardiology programs use HeartFlow for non-invasive coronary physiology assessment - AI enabling cardiologists to guide treatment decisions with functional information without risking invasive catheterization for patients who may not need it.
  • HeartFlow is a medical AI company with FDA clearance that creates a digital 3D model of a patient's coronary arteries from a standard CT scan - using computational fluid dynamics and AI to simulate blood flow and calculate fractional flow reserve (FFR) without requiring invasive catheterization.
  • HeartFlow FFRCT gives cardiologists a non-invasive way to assess whether coronary artery narrowings are functionally significant, enabling more informed treatment decisions.

Watch-outs

  • Requires high-quality CT coronary angiography input: HeartFlow's AI model is built from CT coronary angiography images — image quality requirements are higher than routine CT, requiring appropriate scanner protocols and experienced technologists.
  • Per-analysis pricing adds cost per patient: HeartFlow charges per patient analysis — hospitals must build the per-analysis cost into cardiology program economics and ensure appropriate patient selection to maximize clinical and economic value.
  • Cardiologist interpretation still required: HeartFlow generates FFR results and 3D models but cardiologists must interpret findings in the context of the full clinical picture — AI does not replace cardiac imaging expertise.

Pricing

HeartFlow FFRCT priced per patient analysis. Approximately $1,000 to $1,500 per analysis. Hospital enterprise agreements negotiated for volume pricing. Annual contracts.